Italy

Italy stands as a premier global life sciences hub, distinguished by its sophisticated pharmaceutical manufacturing capabilities and a rapidly expanding biotechnology sector.

As Europe's second-largest producer of medicines, the Italian ecosystem is renowned for its excellence in advanced therapy medicinal products (ATMPs), including pioneering work in gene therapies and regenerative medicine.

The country's medical device industry is equally robust, driven by a dense network of specialized clusters in Lombardy and Emilia-Romagna that excel in diagnostic imaging, electromedical equipment and biomedical instruments.

Italy's healthcare innovation is fueled by a world-class academic research infrastructure, boasting a high density of scientific publications and patents per capita, particularly in oncology and rare diseases.

Integration of AI in healthcare is a key strategic priority, with significant investments from the National Recovery and Resilience Plan (PNRR) accelerating digital health and telemedicine adoption.

For global investors, Italy offers a competitive CDMO landscape, providing high-quality, export-oriented production of APIs and biosimilars.

This multidisciplinary synergy between clinical trial excellence, STEM talent and specialized life science incubators positions Italy as a critical destination for foreign direct investment (FDI) and international R&D collaborations.